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Agenda 
DHI Board Meeting: Wednesday 22nd November 2017, 4.30pm ± 7pm 
Venue: Inovo Board Room, Ground Floor, 121 George St, Glasgow 
 
1. 
 
Welcome 
 
 JJ 
2. 
 
Apologies 
 
 JJ 
 
3. 
 
Declarations of Interest 
 
 All 
 
4. 
 
Minutes of Previous Meeting (Paper 1) 
 
 JJ 
 
5. &KDLUPDQ¶V8SGDWH- Verbal  JJ 
 
6. 
 
Chief Executive Update (Paper 2) For Information GC 
 
7. 
 
Finance Update to end of October 2017 (Paper 3) For Information HA 
 
8. 
 
Revised Governance Arrangements (Paper 4) 
(Including appendices 1-6) 
 
For Approval 
HA 
9. DHI Progress, Planning and Design Update (Paper 5 
with Appendix 1) 
 
For Information 
JH 
10. 
 
DHI KPI Update (Paper 6) For Approval JH 
 
11. 
 
Commercial Development Update (Paper 7) For Information HA 
 
12. Corporate Risk Register For Discussion JJ/GC 
 
13. Date and Time of Next Meeting  
Wednesday 14th February 2018, 10am ± 1.30pm.  
Glasgow - Venue to be confirmed 
 
 All 
 
 
 
 
 
 
 
 
 
 DIGITAL HEALTH & CARE INSTITUTE                                                                                   PAPER 1  
ITEM NO. 4    
BOARD MEETING  
 
Minutes: Wednesday 16th August 2017 
Chairing: 
 
Mr John Jeans  
 
Present: Professor George Crooks 
Chief Executive Officer 
Digital Health & Care Institute 
 David Littlejohn 
Executive Dean,  
University of Strathclyde 
 
 Louise McKean 
Solicitor and Contracts Manager 
University of Strathclyde  
 
 Mr Hugh Anderson, 
Commercial Finance 
Director,  
Digital Health & Care 
Institute 
 
 Mr Don McIntyre,  
Design Director, 
Glasgow School of Art 
 Colin Kirkpatrick, Research 
and Enterprise 
Glasgow School of Art 
 
 Helen Raftopoulos, 
Assistant Director, 
Scottish Funding Council 
 James Cameron, 
Head of Health and Life 
Sciences, 
Highlands & Islands 
Enterprise 
 
 Ms Julia Brown, 
Healthcare, Life and Chemical Sciences, 
Scottish Enterprise 
  
   Charles Sweeney, CEO, 
Critiqom 
Conference line %ULDQ2¶&RQQRU&KDLU(XURSHDQ&RQQHFWHG
Health Alliance, UK 
  
Apologies Ms Donna Chisholm 
Regional Head of Sectors, Innovation and 
Programmes, 
Highlands & Islands Enterprise 
 
 Professor Harry Burns 
University of Strathclyde 
 Irene McAra-McWilliam 
Deputy Director (Innovation) 
Glasgow School of Art 
 
 Mr Alistair Hodgson 
Scottish Government 
 Professor Andrew Morris 
University of Edinburgh 
 Ms Margaret Whoriskey 
Head of Technology Enabled 
Care and Digital Healthcare 
Innovation, 
Scottish Government 
Visiting 
attendees 
 
Mr Stuart Deed, 
Strategic Partnering Director, 
Digital Health & Care Institute 
 Mr Chaloner Chute 
Chief Technology Officer, 
Digital Health & Care 
Institute 
Board Secretary Shirley Sharp, Office Manager/EPA, Digital 
Health & Care Institute 
 
  
 
 
 
 ACTION BY 
1. &KDLU¶V,QWURGXFWLRQDQG$SRORJLHV 
 
7KH&KDLUZHOFRPHGHYHU\RQH WR WRGD\¶VPHHWLQJDQGVXEPLWWHGDSRORJLHVRQ
behalf of those unable to attend.   
 
 
2. Declarations of Interest 
The Chair advised that for information and without conflict, he is co-chair for a 
National Centre for Universities and Business Task Force on Digital Health and 
Healthy Living. 
 
 
 
3. 
 
 
 
 
 
3.1 
Minutes and Actions from the Previous Meeting 
SS advised the attendance for Julia Brown at the May and July meetings has 
been amended.  
Chairs Introduction and Apologies ± Paragraph 4, the chair reiterated that 
currently this is proposed funding for UK Government. 
 
Actions from the Previous meeting (24/07/17) 
 
AOB - LMcK raised the issue of £250k capex re demonstrator environment and 
clarification from SFC. HR advised she will confirm after receipt of an email, 
including details from DHI Chief Technology Officer, Chaloner Chute. LMcK 
advised that this has been sent 
 
AOB - DHI/SG Visit to Estonia. Chaloner Chute to send completed report to SS 
for dissemination to colleagues. 
 
AOB - Chairs of IC Group ± Business Case Approval Assessment by SFC. 
The Chair advised that Stuart Fancy from SFC has arranged a meeting with 
'LUHFWRU*HQHUDO¶VIURP6FRWWLVK*RYHUQPHQWDQG&KDLUVWRXSGDWH7KHUHUHPDLQ
concerns about the assessment criteria and process. The Chair will plan to join 
the meeting by teleconference and update colleagues at the next scheduled DHI 
Board meeting in November.  
 
Chair advised that letters of appointment will be issued to Board members in 
September. Updates from Board colleagues will also be required re declarations 
of interest. 
 
The Chair also advised on Industrial Strategy Challenge Fund and the potential 
for UK Government providing significant investment for industry, with healthcare 
 
 
 
 
 
 
 
 
 
HR 
 
 
 
CC/SS 
 
 
 
 
 
JJ 
 
 
 
 
 
GC 
 
 
 
being an area of focus. There is also the possibility of grant initiatives from 
Innovate UK. JJ and GC will look at how these initiatives are being set and how 
DHI can tie into this. 
 
 
 
 
JJ/GC 
4. Chief Executive Update 
GC advised colleagues to note the new format for the Board pack, which should 
hopefully offer a more condensed and structured format for Board colleagues to 
review.  
 
GC also advised that DHI Head Quarters have now officially moved into the 1st 
floor of the Inovo Building from 1st August. The dilapidations are still an ongoing 
issue with the previous landlord, however Hugh Anderson and University of 
Strathclyde are in discussions to finalise the agreed sum to be paid. 
 
GC advised that DHI has had constructive discussions with Scottish Government 
colleagues re links with DHI. GC has met with Margaret Whoriskey, Head of 
Technology Enabled Care and Digital Healthcare Innovation, who is comfortable 
with taking on that informal role as DHI Government sponsor. GC will attend 
regular meetings with MW and the division going forward and GC will update 
colleagues as appropriate. 
 
GC advised that from 1st July 2017 until the end of the year, Estonia is assuming 
presidency of the EU Council. With a commitment to the development of Digital 
Public Services, GC has been invited to participate in the Task Force focussing 
on Digital Transformation and change management in health and social care 
RUJDQLVDWLRQV*&KRSHV WR UHSUHVHQWDQGSURPRWH6FRWODQG¶V LQWHUHVWV LQ WKLV
area and DHI going forward. 
 
HA commented that the Estonia visit has been a worthwhile visit and validation of 
'+,¶VDSSURDFKJRLQJIRUZDUG 
 
The Chair asked colleagues for comment/views on the new document format. It 
was agreed that this clearer and more concise format should continue. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5. Finance Update 
Before HA addressed the Board with the finance update JJ asked HR for an 
update re report to SFC Strategic Fund Group and utilisation of proposed funds 
from phase 1 for phase 2. HR advised that the report was received too late for 
GLVFXVVLRQDWWKLVPRQWK¶s meeting and will be discussed at the next meeting at 
WKHEHJLQQLQJRI6HSWHPEHU--HQTXLUHGDVWRWLPHOLQHVRQQRWLILFDWLRQRI6)&¶V
response HR advised that this would perhaps turnaround within one or two days. 
HR advised that she has all the information required and would hope for a positive 
outcome.  
 
JJ advised that he had recently met with Stuart Fancy, SFC and had advised on 
a slight change to the terminology used with regard to Phase 2. SFC would prefer 
Phase 1A being used going forward. 
 
HA advised colleagues on the first quarter Phase 1A - April/May/June. No 
concerns currently with a cash positive position. Capex is still being deliberated 
over. HR advised that she has received the information required from DHI/UoS 
and this will be advised to DHI by the end of next week. JJ asked for clarification 
if this was DHI or UoS? DL confirmed this will be UoS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HR 
 
 
 
6. Risk Register 
GC advised that DHI is developing its formal risk management processes and 
procedures. The SMT have collectively developed and updated the Strategic Risk 
Register for consideration by the Board. The Risk Register will form part of the 
governance system for DHI. JJ advised that this is a great start to the process 
and he will work with GC on its refinement and return to the next Board for 
comment/review at the next Board meeting. DL reassured the Board that DHI is 
part of the Universities Internal Key Controls Process re operations and practices 
within the University. DL confirmed that this has been submitted to the Head of 
School, which will then go to the Dean for review.  
 
 
 
 
 
 
JJ/GC 
 
 
 
 
7. Challenge Areas Update ± Chaloner Chute 
--DGYLVHGWKDW&&LVDWWHQGLQJWRGD\¶V%RDUGPHHWLQJWRJRWKURXJKWKLVKLJK-
level update on the challenges proposed at the extraordinary Board meeting in 
July, seeking full sign off from the Board for Phase 1A going forward.  
 
CC advised that he will provide a summary of the challenges agreed with key 
stakeholders identified. CC asked colleagues to note that the six challenges and 
the simulation toolkit outlined account for the majority of DHI funding; the financial 
aspects of the Challenge process are included in Paper 5. 
 
CC discussed in turn the six Challenges highlighted in Appendix: Challenge 
Summary of paper 4. Each challenge identifies the policy alignment, senior 
service leadership, clinical leadership, industry interest and potential route to 
market. A detailed discussion took place, with particular focus on each challenge 
and its sponsorship, deliverables, adoption, which in turn can lead to the 
commissioning of a new service.  
 
JJ then asked HA to give colleagues an overview of the proposed financial plan 
of phase 1A.  
 
HA pointed out that the focus of paper 5 was to give a balanced and proportionate 
view without affecting future business outputs. HA asked colleagues to note the 
cost reduction elements highlighted in Chart 1. Cause of Change within paper 5. 
A £520k reduction in staff costs, 3 leavers within the design team not being 
replaced, reducing their complement to 8.4 FTE. There are also several technical 
and commercial heads that are not being recruited. Overall reduction based on 
the original plan submitted to SFC in December 2016 shows a reduction of five 
staff. 
HA proposed that the next business phase commence 3 months early on 1st 
January 2019, saving £480k in this final quarter. JJ advised that this was raised 
at his meeting with Stuart Fancy, and he is comfortable (in principle) with an 
earlier application from DHI. August 2018 will therefore be a critical Board 
meeting. HA also advised that costs associated with developing the 
infrastructures in the demonstration toolkit have been reduced by £450k (50%). 
Anything beyond the foundation structures is dependent on corporate partners 
and 3rd party grants. The calculation of overheads associated with all academic 
grant work has been changed from 80% to 70% for phase 1A. This will have an 
impact on all academic institutions who receive grant allocations from DHI 
through this phase. CK advised that 80% is the standard across the sector but is 
comfortable with 70% as a short-term solution for a minimum period of time. CK 
also advised that if, during that period funding becomes available, then he would 
hope this would be revised.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
JJ advised that the reduction in funds for marketing could be an issue and that 
DHI needs to take a creative approach to raise its profile. JJ asked for Board 
colleagues to consider and assist in this area. DL suggested discussion between 
DHI Marcoms and UoS would be useful. 
 
JJ then asked colleagues to review all the 6 Challenge areas, the proposed toolkit 
and balanced budget and to endorse this package. Board colleagues were in full 
agreement with the business plan going forward for Phase 1A. 
  
 
All 
 
 
 
 
 
 
 
8. Commercial Update 
JJ advised that SD would inform colleagues on the potential commercial partners, 
this would be for information only and not for approval. 
SD advised that DHI has identified target areas where financial, technical and 
personnel support are potentially available to bridge the financial shortfall in DHI 
Phase 1A. These areas include commercial partnerships with industry, the 
progression of Third Sector directly funded projects and grant funding. The 
targeted additional third party funding for Phase 1A is £800k. 
 
JJ asked what can DHI promise in the short-term, given that the future business 
case is uncertain? SD advised that those partners currently in discussions with 
DHI are confident and comfortable with the identified risks. 
SD then went on to advise colleagues about ongoing discussions with IBM, Capita 
Consulting and Scottish Wide Area Network (SWAN) re demonstration and 
simulation facilities. SD also advised that Macmillan Cancer Care are exploring 
the potential of a second phase to their existing project with DHI. Discussions are 
also underway with the British Heart Foundation and work is ongoing towards a 
grant funding application with Digital Health Technology Catalyst, through 
Innovate UK. JJ asked for SD to return to the November Board meeting to present 
funding opportunities going forward, specifically where this will relate to the 
current pipeline of work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SD 
 
 
 
9. AOB 
JJ advised that the November Board meeting will be scheduled to a later time on 
the same date, to allow colleagues to attend the SG sponsored Digital Health and 
Technology Event that same day. This event will be held in the new Technology 
and Innovation Centre and if possible, the Chair will arrange for the Board meeting 
to take place in the Inovo building; the meeting will take place from 4.30pm until 
7.00pm. 
 
 
10. Date and Time of Next Meeting 
The next scheduled meeting will take place on Wednesday 22nd November @ 
4.30pm, Board Room, Ground Floor, Inovo Building, Glasgow. 
 
 
 
 
 
 
 
